Association between viral infection and bronchopulmonary dysplasia in preterm infants: a systematic review and

Xin Guo1, Defei Ma1, Rui Li1

  • 1Department of Neonatology, Longgang District Maternity & Child Healthcare Hospital of Shenzhen City (Longgang Maternity and Child Institute of Shantou University Medical College), Shenzhen, 518172, Guangdong, China.

PubMed

Insights

Viral infections, particularly cytomegalovirus (CMV), are linked to a higher risk of bronchopulmonary dysplasia (BPD) in preterm infants. Further research is needed to confirm this association and explore prevention strategies.

Area of Science:

  • Neonatal Medicine
  • Pediatric Pulmonology
  • Infectious Diseases

Background:

  • Bronchopulmonary dysplasia (BPD) is a primary complication in very preterm infants (VPI) and very low birth weight (VLBW) infants.
  • Viral infections are suspected contributors to BPD development, but evidence remains inconsistent.

Purpose of the Study:

  • To systematically review and meta-analyze the association between viral infections and BPD in preterm infants.
  • To identify specific viruses implicated in the etiopathogenesis of BPD.

Main Methods:

  • Systematic literature search of PubMed, Embase, Web of Science, and Cochrane Database up to December 19, 2023.
  • Inclusion of observational studies on viral infections and BPD in preterm infants.
  • Risk of bias assessment using the Newcastle-Ottawa Scale (NOS).

Main Results:

  • A significant association was found between viral infection and BPD diagnosed at 36 weeks postmenstrual age (OR: 2.42).
  • Cytomegalovirus (CMV) showed a significant association with BPD at 36 weeks postmenstrual age (OR: 2.34).
  • No significant association was detected for BPD diagnosed on day 28 of life, likely due to small sample sizes.

Conclusions:

  • Viral infections, especially CMV, increase the risk of BPD in preterm infants.
  • High-quality prospective studies with large samples are necessary to validate these findings.
  • Further research, including randomized controlled trials, is needed to evaluate interventions for viral infections in preventing BPD.

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
205
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
230
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
1.6K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
324
Factors Affecting Pulmonary Ventilation01:19

Factors Affecting Pulmonary Ventilation

Besides the pressure difference between the external environment and the lungs, the airflow rate and ease of pulmonary ventilation are also influenced by three other factors: surface tension of the fluid in the alveoli, compliance of the lungs, and airway resistance.
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
1.4K